{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:31:35Z","timestamp":1782552695958,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81970637"],"award-info":[{"award-number":["81970637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81903972"],"award-info":[{"award-number":["81903972"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"shanghai sailing program","award":["19YF1406700"],"award-info":[{"award-number":["19YF1406700"]}]},{"name":"shanghai sailing program","award":["20YF1406000"],"award-info":[{"award-number":["20YF1406000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies show that abnormal lipoprotein metabolism can increase the prevalence of chronic kidney disease (CKD). This study prospectively investigated the association of triglycerides to high-density lipoprotein cholesterol (TG\/HDL-C) ratio and renal dysfunction in the Chinese population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This longitudinal cohort research examined 7,316 participants (age range: 22\u201393) from the China Health and Retirement Longitudinal Study (CHARLS), including 6,560 individuals with estimated glomerular filtration rate (eGFR)\u2009\u2265\u200960 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> (normal renal function, NRF) group and 756 with eGFR\u2009&lt;\u200960 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> (impaired renal function, IRF) group. In NRF group, reduction in renal function was defined as eGFR\u2009&lt;\u200960 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> at exit visit and in IRF group, it was defined as decline in eGFR category, average eGFR decline\u2009&gt;\u20095 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> per year or &gt;\u200930\u2009% decrease in eGFR from baseline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study results showed that TG\/HDL-C ratio was positively associated with the risk of renal function decline in the NRF group (OR 1.30, 95\u00a0%CI 1.03\u20131.65, <jats:italic>P<\/jats:italic>\u2009=\u20090.03) and the IRF group (OR 1.90, 95\u00a0%CI 1.21\u20133.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.02) when adjusting for age, gender, obesity, diabetes, hypertension, waist circumference, drinking, smoking, history of heart disease and stroke, low-density lipoprotein cholesterol and eGFR category. Analysis of the IRF group indicated that relative to the group of TG\/HDL-C\u2009&lt;\u20091.60, the group of TG\/HDL-C\u2009\u2265\u20092.97 had an increased risk for the decline of eGFR category (OR 1.89, 95\u00a0%CI 1.12\u20133.21, <jats:italic>P<\/jats:italic>\u2009=\u20090.02) and &gt;\u200930\u2009% decline in eGFR (OR 2.56, 95\u00a0%CI 1.05\u20136.38, <jats:italic>P<\/jats:italic>\u2009=\u20090.04).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The high TG\/HDL-C ratio was an independent risk factor for declining renal function in the Chinese population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01542-5","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T16:06:23Z","timestamp":1632153983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The effect of triglycerides to high-density lipoprotein cholesterol ratio on the reduction of renal function: findings from China health and retirement longitudinal study (CHARLS)"],"prefix":"10.1186","volume":"20","author":[{"given":"Shiqi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"1542_CR1","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-266."},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"1542_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1681\/ASN.2006080919","volume":"17","author":"E Ritz","year":"2006","unstructured":"Ritz E, Wanner C. Lipid changes and statins in chronic renal insufficiency. J Am Soc Nephrol. 2006;17:226\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167\u201374.","journal-title":"Ann Intern Med"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","volume":"166","author":"NI Parikh","year":"2006","unstructured":"Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006;166:1884\u201391.","journal-title":"Arch Intern Med"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00467-007-0467-5","volume":"22","author":"JM Saland","year":"2007","unstructured":"Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol. 2007;22:1095\u2013112.","journal-title":"Pediatr Nephrol"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","volume":"293","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. Jama. 2005;293:1737\u201345.","journal-title":"Jama"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","volume":"129","author":"FM Sacks","year":"2014","unstructured":"Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E, Wanner C, Al-Rubeaan K, Aronson R, Barzon I, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 2014;129:999\u20131008.","journal-title":"Circulation"},{"key":"1542_CR9","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","volume":"96","author":"JM Gaziano","year":"1997","unstructured":"Gaziano JM, Hennekens CH, O\u2019Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520\u20135.","journal-title":"Circulation"},{"key":"1542_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.ATV.17.6.1114","volume":"17","author":"J Jeppesen","year":"1997","unstructured":"Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol. 1997;17:1114\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.amjcard.2012.02.016","volume":"109","author":"MR Salazar","year":"2012","unstructured":"Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, Balb\u00edn E, Dulbecco CA, Aizpur\u00faa M, Marillet AG, Reaven GM. Relation among the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012;109:1749\u201353.","journal-title":"Am J Cardiol"},{"key":"1542_CR12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","volume":"139","author":"T McLaughlin","year":"2003","unstructured":"McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802\u20139.","journal-title":"Ann Intern Med"},{"key":"1542_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.12.037","volume":"233","author":"K Tsuruya","year":"2014","unstructured":"Tsuruya K, Yoshida H, Nagata M, Kitazono T, Hirakata H, Iseki K, Moriyama T, Yamagata K, Yoshida H, Fujimoto S, et al. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population. Atherosclerosis. 2014;233:260\u20137.","journal-title":"Atherosclerosis"},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cca.2011.10.021","volume":"413","author":"HT Kang","year":"2012","unstructured":"Kang HT, Kim JK, Kim JY, Linton JA, Yoon JH, Koh SB. Independent association of TG\/HDL-C with urinary albumin excretion in normotensive subjects in a rural Korean population. Clin Chim Acta. 2012;413:319\u201324.","journal-title":"Clin Chim Acta"},{"key":"1542_CR15","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s11255-019-02287-y","volume":"51","author":"L Yu","year":"2019","unstructured":"Yu L, Zhou L, Zhou D, Hu G. Nonlinear relationship between triglyceride\/high-density lipoprotein cholesterol ratio and chronic kidney disease in US adults: a National Health and Nutrition Examination Survey investigation. Int Urol Nephrol. 2019;51:2005\u201314.","journal-title":"Int Urol Nephrol"},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2147\/DMSO.S229362","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Chen H, Shao X, Xiong C, Hong G, Chen J, Li X, You X, Gao P, Chen Y, et al. Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China. Diabetes Metab Syndr Obes. 2020;13:663\u201370.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet. 2012;379:815\u201322.","journal-title":"The Lancet"},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12963-014-0028-7","volume":"12","author":"Y Huang","year":"2014","unstructured":"Huang Y, Gao L, Xie X, Tan SC. Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metr. 2014;12:28.","journal-title":"Popul Health Metr"},{"key":"1542_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43:61\u20138.","journal-title":"Int J Epidemiol"},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"109312","DOI":"10.1016\/j.envres.2020.109312","volume":"184","author":"S Lv","year":"2020","unstructured":"Lv S, Shen Z, Zhang H, Yu X, Chen J, Gu Y, Ding X, Zhang X. Association between exposure to the Chinese famine during early life and the risk of chronic kidney disease in adulthood. Environ Res. 2020;184:109312.","journal-title":"Environ Res"},{"key":"1542_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: Accuracy and Use for Population Estimates. Am J Kidney Dis. 2010;56:32\u20138.","journal-title":"Am J Kidney Dis"},{"key":"1542_CR22","unstructured":"KDIGO. 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl (2011) 2013;3:1-150."},{"key":"1542_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.18441120","volume":"16","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, He P, Liu M, Zhou C, Liu C, Li H, Zhang Y, Li Q, Ye Z, Wu Q, et al. Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function. Clin J Am Soc Nephrol. 2021;16:889\u201397.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","volume":"79","author":"BC Astor","year":"2011","unstructured":"Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331\u201340.","journal-title":"Kidney Int"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93\u2013104.","journal-title":"Kidney Int"},{"key":"1542_CR26","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"1542_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ki.2010.536","volume":"79","author":"M van der Velde","year":"2011","unstructured":"van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79:1341\u201352.","journal-title":"Kidney Int"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1681\/ASN.V1482084","volume":"14","author":"ES Schaeffner","year":"2003","unstructured":"Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084\u201391.","journal-title":"J Am Soc Nephrol"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2000","unstructured":"Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58:293\u2013301.","journal-title":"Kidney Int"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.291.7.844","volume":"291","author":"CS Fox","year":"2004","unstructured":"Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. Jama. 2004;291:844\u201350.","journal-title":"Jama"},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2147\/DMSO.S217326","volume":"12","author":"Z Wu","year":"2019","unstructured":"Wu Z, Jiang Y, Jia J, He D, Sun P, Li J, Huo Y, Fan F, Zhang Y. Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population. Diabetes Metab Syndr Obes. 2019;12:2085\u201393.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1542_CR32","doi-asserted-by":"crossref","unstructured":"Kim J, Bae YJ, Shin SJ, You HS, Lee JW, Kang HT. The ratio of triglycerides to high-density lipoprotein cholesterol is associated with the risk of chronic kidney disease in Korean men. Lipids 2021.","DOI":"10.1002\/lipd.12314"},{"key":"1542_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1053\/j.ajkd.2015.05.011","volume":"66","author":"K Tsuruya","year":"2015","unstructured":"Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, Fujimoto S, Konta T, Moriyama T, Yamagata K, et al. Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population. Am J Kidney Dis. 2015;66:972\u201383.","journal-title":"Am J Kidney Dis"},{"key":"1542_CR34","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290:F262\u201372.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1542_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/01.ASN.0000112912.40303.81","volume":"15","author":"NJ Brunskill","year":"2004","unstructured":"Brunskill NJ. Albumin signals the coming of age of proteinuric nephropathy. J Am Soc Nephrol. 2004;15:504\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"1542_CR36","first-page":"33","volume":"12","author":"AB Magil","year":"1999","unstructured":"Magil AB. Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Mod Pathol. 1999;12:33\u201340.","journal-title":"Mod Pathol"},{"key":"1542_CR37","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.amjcard.2005.10.036","volume":"97","author":"NC Bhalodkar","year":"2006","unstructured":"Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97:1007\u20139.","journal-title":"Am J Cardiol"},{"key":"1542_CR38","doi-asserted-by":"crossref","unstructured":"Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, Athyros V, de Graaf J, M\u00e4rz W, Parhofer KG, et al. \u201cEuropean panel on low density lipoprotein (LDL) subclasses\u201d: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol. 2011;9:531\u20132.","DOI":"10.2174\/157016111796642698"},{"key":"1542_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/diacare.14.3.173","volume":"14","author":"RA DeFronzo","year":"1991","unstructured":"DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173\u201394.","journal-title":"Diabetes Care"},{"key":"1542_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.numecd.2008.09.003","volume":"19","author":"F Hadaegh","year":"2009","unstructured":"Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009;19:401\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1542_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ndt\/16.6.1189","volume":"16","author":"CH Bolton","year":"2001","unstructured":"Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189\u201397.","journal-title":"Nephrol Dial Transplant"},{"key":"1542_CR42","doi-asserted-by":"publisher","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","volume":"298","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010;298:F662\u201371.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01542-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T16:09:00Z","timestamp":1632154140000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01542-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of Peking University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and\u00a0<!--Emphasis Type='Bold' removed-->consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}